Psychiatrists

Three parts of your work where AI is already doing real lifting, and what stays yours.

• Moral treatment1812–1900

  Moral treatment and asylum architecture (pre-pharmacological era)

  The first tool of the nineteenth-century asylum physician was the institution itself. Moral treatment, imported from Pinel in France and Tuke in England, held that a structured, humane, therapeutically-designed environment could restore mental health. The asylum superintendent's task was to manage this environment: patient scheduling, occupational therapy, diet, exercise, climate, social interaction, all calibrated to promote reason over disturbed affect. Thomas Kirkbride of the Pennsylvania Hospital developed what became known as the Kirkbride Plan in 1854, an architectural model for asylums that shaped American institutional construction for decades. Clinical tools of the era included cold-water hydrotherapy, mechanical restraints (intended to replace more punitive physical restraints), and early attempts at pharmaceutical sedation using opiates and bromide salts. The physician's primary instrument was observation and the interview; no laboratory diagnostics existed for mental illness.

  Effect on the work

  The moral treatment model justified the existence of the asylum superintendent as a medical professional rather than a jailer. It created the first distinct psychiatric labor market: by 1880, many major public and private asylums operated in the United States, each employing a superintendent and one to several assistant physicians.

• Psychoanalysis1900–1952

  Psychoanalysis and somatic therapies (Freud, ECT, insulin coma, lobotomy era)

  The early twentieth century delivered two parallel streams of clinical tools to psychiatry. The first, psychoanalysis, arrived from Vienna: Freud's ideas reached American physicians at the Clark Conference of 1909, and by the 1920s psychoanalytic training was reshaping psychiatric residency programs and attracting the profession toward private outpatient practice for the first time, pulling practitioners out of the asylum and into the consulting room. The second stream was somatic: insulin coma therapy (Sakel, 1927), metrazol convulsive therapy (Meduna, 1934), electroconvulsive therapy (Cerletti and Bini, 1938), and prefrontal lobotomy (Moniz, 1935; Freeman and Watts, U.S., 1936). ECT proved genuinely effective for severe depression and remains in use today; lobotomy was overused, ultimately discredited, and resulted in tens of thousands of procedures in the United States before being abandoned. The clinical tool set of this era gave psychiatrists something that moral treatment had not: physical interventions that could be applied in inpatient settings and claimed as medical procedures.

  Effect on the work

  Psychoanalytic training drew psychiatrists toward private practice, creating a class stratification within the profession: analytically trained practitioners in major cities commanding high fees for outpatient therapy, asylum-based psychiatrists managing large institutional caseloads. By 1950, psychiatry had the highest average fee-for-service income of any medical specialty, reflecting the prestige of the analytic model.

• First-generation antipsychotics1952–1980

  First-generation antipsychotics and antidepressants (chlorpromazine 1954, imipramine 1958, lithium 1970)

  Chlorpromazine (Thorazine, approved by the FDA in 1954) is the single most consequential pharmaceutical in psychiatric history. Within eight months of its U.S. approval, it had been administered to over two million patients. The inpatient population of U.S. mental institutions, which had reached a historic peak of 559,000 in 1955, fell to 452,000 by 1965 and continued declining for decades. Chlorpromazine did not cure schizophrenia, but it made the most disturbing symptoms manageable enough for patients to leave the hospital. Imipramine (the first tricyclic antidepressant, 1958) and lithium (approved for mania in the U.S. in 1970) extended pharmacological reach into depression and bipolar disorder. These drugs transformed the psychiatrist's role: the prescription pad became the central clinical instrument, displacing the asylum environment as the primary treatment modality. The DSM-I (1952) and DSM-II (1968) provided diagnostic scaffolding but remained psychoanalytically oriented, bundling conditions in ways that made prescribing decisions more art than algorithm.

  Effect on the work

  Deinstitutionalization, accelerated by chlorpromazine and by the Community Mental Health Centers Act of 1963 (signed by President Kennedy), shifted psychiatrists from asylum employment to community mental health centers and private practice. The promise of community care for discharged patients was only partially fulfilled, contributing to the visible increase in untreated severe mental illness in urban areas by the 1980s.

• DSM-III revolution1980–2000

  DSM-III revolution and second-generation psychopharmacology (SSRIs, atypical antipsychotics, managed care EHRs)

  The DSM-III (1980) was the most consequential revision of American psychiatric nosology since the profession's founding. It replaced the psychoanalytic vocabulary of DSM-I and DSM-II with explicit, operationalized diagnostic criteria: symptom checklists, duration requirements, exclusion rules. The goal was reliability across raters, and the manual largely achieved it. DSM-III had hundreds of diagnostic categories and hundreds of pages; it turned psychiatric diagnosis into a protocol-driven exercise rather than a clinical art. Prozac (fluoxetine) arrived in 1988, launching the SSRI era and making psychiatric medications a mass-market product for the first time: primary care physicians began prescribing antidepressants directly, and psychiatrists increasingly specialized in complex cases that primary care could not manage. Managed care and insurance formularies imposed new constraints: the psychotherapy hour gave way to the medication management visit. EHR adoption in inpatient psychiatric settings began in the 1990s, introducing the documentation burden that would later define the AI augmentation opportunity.

  Effect on the work

  The DSM-III shift, combined with SSRI market penetration and managed care, bifurcated psychiatry into two practice models: brief pharmacological management (the majority of psychiatric visits by the 1990s) and specialty psychotherapy (increasingly performed by psychologists and licensed clinical social workers rather than physicians). Psychiatrists became de facto psychopharmacologists in many settings. The med check, a product of managed care reimbursement structures, compressed clinical interactions in ways that increased documentation burden relative to time with patients.

• EHR mandates2000–2020

  EHR mandates, telepsychiatry, and genomics pilots (Meaningful Use 2009, Ryan Haight Act 2008)

  The Health Information Technology for Economic and Clinical Health Act (HITECH) of 2009 accelerated EHR adoption across all medical specialties, including psychiatry. For psychiatrists, the EHR brought a specific burden: behavioral health notes, which often run longer and contain more sensitive information than standard medical notes, became subject to structured documentation templates, billing compliance requirements, and third-party payer review. Surveys from this era consistently documented that psychiatrists spent as much as a third of their clinical time on documentation rather than patient care. Telepsychiatry pilots had existed since the 1990s, but the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 imposed an in-person visit requirement before controlled substances could be prescribed via telemedicine, limiting psychiatric telehealth growth. Rural and underserved areas, which faced the most acute psychiatrist shortages, were partially served by consultation-liaison models and teleconsult programs. Early pharmacogenomics research on CYP450 variants and antidepressant response began reaching clinical practice in this decade.

  Effect on the work

  Documentation burden became the defining quality-of-life issue in psychiatric practice. The time cost of documentation effectively reduced the number of patients any given psychiatrist could see, amplifying the access shortage.

• Ambient AI scribes2020–present

  Ambient AI scribes, pharmacogenomics AI, digital therapeutics, and telepsychiatry at scale (COVID-19 waiver era)

  COVID-19 forced telepsychiatry from fringe to mainstream in weeks: the Ryan Haight Act in-person requirement was waived on March 16, 2020, and telehealth psychiatric visits increased by over 50% in the first quarter of 2020 compared to 2019. By 2021, nearly all physicians were using some form of telehealth. For psychiatry, this was the most rapid structural change to the delivery model since deinstitutionalization. Simultaneously, ambient AI scribes (Eleos Health, Nuance DAX Copilot, renamed Microsoft Dragon Copilot in March 2025) began penetrating behavioral health settings, offering to recover the many minutes per clinical day psychiatrists had been losing to documentation since the EHR era began. Pharmacogenomics AI platforms (GeneSight, Genomind) provided psychiatrists with CYP450 phenotype data that genuinely improved prescribing decisions in treatment-resistant cases: the GeneSight RCT (JAMA Psychiatry 2019) found a 26% improvement in symptom response for treatment-resistant patients. Digital therapeutics (Woebot, Wysa, Limbic Access) extended psychiatric reach between sessions. The APA issued a formal position statement on AI in psychiatry in 2023 (updated 2025) affirming that AI tools serve as clinical decision support, not autonomous prescribers, with all legal and ethical responsibility remaining with the human psychiatrist.

  Effect on the work

  A 2025 multi-site RCT published in JAMA found ambient AI scribes reduced after-hours documentation ("pajama time") by 62% and improved physician satisfaction with no degradation in note quality. NEJM AI (2025) found that ambient scribes in outpatient psychiatry reduced note completion time per session. The augmentation story is measurable: psychiatrists using these tools can see more patients per day without extending total work hours, directly addressing the access shortage.